Viking Therapeutics, Inc. Return On Equity in % from Q1 2018 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Viking Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2018 to Q3 2025.
  • Viking Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2025 was -29.4 %, a 130% decline year-over-year.
  • Viking Therapeutics, Inc. annual Return On Equity for 2024 was -12.1 %, a 56.6% increase from 2023.
  • Viking Therapeutics, Inc. annual Return On Equity for 2023 was -27.8 %, a 35.1% increase from 2022.
  • Viking Therapeutics, Inc. annual Return On Equity for 2022 was -42.8 %, a 70.5% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)

Viking Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -29.4 -16.6 -130% Jul 1, 2025 Sep 30, 2025
Q2 2025 -20 -4.93 -32.8% Apr 1, 2025 Jun 30, 2025
Q1 2025 -14.4 +4 +21.7% Jan 1, 2025 Mar 31, 2025
Q4 2024 -12.1 +15.7 +56.6% Oct 1, 2024 Dec 31, 2024
Q3 2024 -12.7 +18.6 +59.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -15.1 +21.2 +58.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -18.4 +30.1 +62.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 -27.8 +15 +35.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -31.3 +3.92 +11.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -36.3 -5.26 -17% Apr 1, 2023 Jun 30, 2023
Q1 2023 -48.5 -20.8 -74.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -42.8 -17.7 -70.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 -35.2 -11.9 -51.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -31 -10.4 -50.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -27.8 -10.2 -58% Jan 1, 2022 Mar 31, 2022
Q4 2021 -25.1 -9.71 -63.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -23.3 -9.74 -71.8% Jul 1, 2021 Sep 30, 2021
Q2 2021 -20.7 -8.78 -73.8% Apr 1, 2021 Jun 30, 2021
Q1 2021 -17.6 -6.64 -60.7% Jan 1, 2021 Mar 31, 2021
Q4 2020 -15.4 -6.34 -70.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 -13.6 -5.47 -67.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -11.9 -3.63 -43.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -10.9 -1.88 -20.8% Jan 1, 2020 Mar 31, 2020
Q4 2019 -9.02 +1.84 +16.9% Oct 1, 2019 Dec 31, 2019
Q3 2019 -8.1 +7.73 +48.9% Jul 1, 2019 Sep 30, 2019
Q2 2019 -8.26 +27.4 +76.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -9.06 +70.6 +88.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -10.9 Oct 1, 2018 Dec 31, 2018
Q3 2018 -15.8 Jul 1, 2018 Sep 30, 2018
Q2 2018 -35.7 Apr 1, 2018 Jun 30, 2018
Q1 2018 -79.7 Jan 1, 2018 Mar 31, 2018

Viking Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -12.1 +15.7 +56.6% Jan 1, 2024 Dec 31, 2024
2023 -27.8 +15 +35.1% Jan 1, 2023 Dec 31, 2023
2022 -42.8 -17.7 -70.5% Jan 1, 2022 Dec 31, 2022
2021 -25.1 -9.71 -63.2% Jan 1, 2021 Dec 31, 2021
2020 -15.4 -6.34 -70.3% Jan 1, 2020 Dec 31, 2020
2019 -9.02 +1.84 +16.9% Jan 1, 2019 Dec 31, 2019
2018 -10.9 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.